Clinical trial
OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac…
NCT00251134 · Stiftung Institut fuer Herzinfarktforschung, Other · Completed
Key facts
| NCT number | NCT00251134 |
|---|---|
| Title | OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction |
| Official title | OMEGA: A Prospective, Randomised, Double-Blind, Placebo-Controlled Multicentre Study in Patients Who Survived Acute Myocardial Infarction to Investigate the Efficacy and Safety of 1 Gram Ω-3-Fatty Acid Ethyl Esters (Ω-3FAE) Daily Versus Placebo to Reduce the Risk of Sudden Cardiac Death. |
| Acronym | OMEGA |
| Lead sponsor | Stiftung Institut fuer Herzinfarktforschung, Other |
| Collaborators | Trommsdorff GmbH & Co. KG Industry Pronova BioPharma |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Zodin (drug), Olive oil (placebo) |
| Enrollment | 3,800 |
| Start date | Oct 1, 2003 |
| Primary completion | Jun 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Nov 9, 2005 |
| Last update posted | Sep 12, 2008 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: